Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Actinogen Medical

    MCap

    AUD115m

    Last close

    AUD0.04

    ▲ 0.00 (11.11%)

    Nykode Therapeutics

    MCap

    NOK757m

    Last close

    NOK2.54

    ▲ 0.23 (9.75%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

BlackRock Greater Europe Investment Trust — Philosophy and process driving outperformance

BlackRock Greater Europe Investment Trust (LSE: BRGE)

Last close As at 04/11/2025

GBP5.92

▲ −7.00 (−1.17%)

Market capitalisation

GBP557m

More on this equity

DISCLAIMER

Content on this client is only available to investors based in the UK.

Please use the tick box below to confirm your location.

More on BlackRock Greater Europe Investment Trust

View All

Investment Companies

BlackRock Greater Europe Investment Trust — Normalised valuations offer a return to form

Investment Companies

BlackRock Greater Europe Investment Trust — Positive prospects for high-quality portfolio

Investment Companies

BlackRock Greater Europe Investment Trust — High-quality fund in underappreciated region
BlackRock Greater Europe Investment Trust_resized

Investment Companies

BlackRock Greater Europe Investment Trust — Long-term outperformance from high-quality fund

Latest from the Investment Companies sector

View All Investment Companies content

Investment Companies

International Public Partnerships — Responsible, growing and protected

Investment Companies

Georgia Capital — Portfolio growth accelerates

Investment Companies

BB Biotech — Turning milestones into momentum

Investment Companies

Lowland Investment Company — Another year of strong outperformance

Research: TMT

Mercia Asset Management — Sustainable model remains undervalued

After 18% growth in FY21, H122 assets under management (AUM) was up only marginally to c £948m, with nine exits resulting in distributions to investors of £39m. Net assets and NAV per share rose by 6% during the period to £186.4m and 42.4p, respectively. Revenue (excluding £2.6m of performance fees) increased 21% y-o-y to £10.1m (88% contracted and recurring) with EPS rising 35% y-o-y to 2.53p, leaving the group with net cash of £52m. Confidence in the sustainability of Mercia’s hybrid model allowed the board to triple the interim dividend to 0.3p per share – we estimate that the shares might offer a prospective FY22 yield of c 2% assuming a more conservative uplift in final dividend than in FY21. Mercia trades on a P/E of 7.3x annualised H122 EPS and at 0.87x H122 NAV, before considering the incremental value of the third-party funds business (we estimate 7p per share at 4% of funds under management).

Continue Reading